Ford’s Dividend Looks Tempting, but Is It Safe?
Ford’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
This guide covers the fees that can affect the Dividend Aristocrats ETF, from management to trading costs, with tips for evaluating their impact.
11,414 articlesFord’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...
A rising tide of investors aims to replace a $65,000 yearly paycheck with dividend income. This report breaks down ho...
A California-based, $1 million dividend portfolio faces notable after-tax headwinds. This analysis compares federal a...
Chasing a 20% dividend yield can tempt even careful investors. This guide explains why high yields often come with bi...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
In 2026, two healthcare real estate REITs stand out for income-focused investors: Community Healthcare Trust and Sabr...
Pfizer’s stock has faced waves of headwinds, but a patient, long-term view can reveal an opportunity. This guide expl...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Despite a slim yield, the WisdomTree U.S. Quality Dividend Growth Fund continues to attract institutional buyers. Her...
FMC Corporation has faced headwinds that can derail even strong portfolios. Here are two words that should make inves...
As markets wobble in early 2026, a handful of Dow Jones dividend stocks offer reliable income for retirees. This repo...